Laboratory Information System (LIS/LIMS): 2026 Buyer's Guide

TL;DR: A laboratory information system (LIS) - also called a LIMS or lab information system - is the software that runs every step of a lab's workflow: receiving orders, tracking samples, interfacing with analyzers, managing QC, delivering results, and reporting to regulators. The US lab software market is growing fast (+737% in keyword search interest over the last six months) as hospital labs and independent reference labs modernize away from legacy systems. This guide covers what a LIS actually does, how it differs from a LIMS and ELN, what compliance it must support (CLIA, CAP, HIPAA), and how to evaluate the right platform for your lab type and volume.

What is a laboratory information system?

A laboratory information system - universally abbreviated LIS - is the central software platform that manages the operational and clinical workflows of a diagnostic laboratory. Every specimen that enters your lab follows a defined journey: an order arrives from a clinician, a specimen is collected and accessioned, it moves through one or more analytical processes, results are reviewed and released, and a report is delivered back to the ordering provider and filed in the patient's record. The LIS manages all of it.

The term LIS is most common in clinical and hospital laboratory settings - the diagnostic lab running chemistry, haematology, microbiology, and transfusion medicine. The term LIMS (Laboratory Information Management System) overlaps heavily but originated in research and industrial laboratories where sample management and chain of custody are the primary concern, and clinical result-reporting workflows are secondary. In 2026, the two terms are largely interchangeable in healthcare contexts - most vendors use them interchangeably, and most buyers mean the same thing when they say either one. Both fall under the broader laboratory management software category. The practical LIMS vs LIS distinction is explored in the comparison table below.

What makes a laboratory information system different from a general EHR or a hospital information system is the depth of lab-specific functionality: instrument interfacing (the ability to receive results directly from analyzers via ASTM or HL7 protocols), specimen tracking with barcode chain of custody, configurable QC rules (Westgard rules, Levey-Jennings plots), reflex and delta-check logic, test-catalog management, and the regulatory reporting that CLIA and CAP require from a certified laboratory.

Without a LIS, a lab runs on paper log books, manual result transcription, and spreadsheet-based QC - an operational model that fails at any meaningful volume and creates patient-safety risks from transcription errors.

LIS vs LIMS vs ELN - settling the terminology

These three terms describe overlapping but distinct categories - all broadly classified as laboratory management software. A clinical LIMS is the subset purpose-built for regulated diagnostic workflows (CLIA/CAP) rather than research or industrial use. Picking the wrong category leads to buying a platform that covers 80% of your needs and is missing the 20% that matters most.

The practical rule: If your lab reports diagnostic results to clinicians or patients and operates under CLIA certification, you need a LIS. If you run a research or industrial lab where sample management and chain of custody are paramount but you're not reporting clinical results, a LIMS is the correct category. If you need both - a hospital lab with a research arm, or a pharmaceutical company running both QC and R&D - some vendors offer platforms that span both.

Core modules every laboratory information system must have

A LIS that's missing any of the following modules is either niche (built for a specific lab type) or legacy (features were never built or haven't been maintained). When you evaluate vendors, ask for a demonstration of each module against your real test menu and workflow - not a slide deck.

Order management and test catalog

The LIS receives test orders from multiple sources: the EHR or HIS (via HL7 ORM messages or FHIR ServiceRequest resources), a patient portal, a paper requisition (scanned and entered manually), or a direct physician order at the lab counter. The test catalog defines every orderable test - its code, specimen requirements, methodology, reference ranges, turnaround time target, and billing codes (CPT). A configurable test catalog is what separates a clinical LIS from a generic sample-management tool.

Key questions to ask vendors: Can the test catalog be maintained by your lab staff without vendor involvement? Does the system support standing orders, reflex orders, and add-on tests? Can it handle test panels (a lipid panel that auto-orders cholesterol, LDL, HDL, triglycerides) with a single order code?

Sample accessioning and chain-of-custody tracking

Accessioning is the formal registration of a specimen into the lab - assigning a unique accession number, labelling with a barcode or 2D code, recording collection time, collector identity, and specimen type. A proper LIS enforces chain of custody at every subsequent step: every scan, every instrument load, every result entry, and every result release is logged against the accession number with a timestamp and user ID.

This chain-of-custody log is not optional. CAP, CLIA, and ISO 15189 all require it. It's also your defence against specimen mix-up liability - if a result is ever disputed, the audit trail shows exactly who handled the specimen and when.

Instrument interfacing

The single most operationally impactful LIS feature is bidirectional instrument interfacing: the ability to download the worklist to an analyzer (so the analyzer knows which tests to run on which specimens) and receive results back electronically without manual transcription. A well-interfaced analyzer pushes results into the LIS in real time; the LIS applies QC rules, delta checks, and reference ranges automatically; and results queue for review without anyone retyping a number.

The dominant interfacing protocols are ASTM E1394 (the legacy standard for most clinical chemistry analyzers - Siemens, Beckman Coulter, Abbott Architect), HL7 v2.x (increasingly used for result delivery), and proprietary TCP/IP connections for newer instruments. A modern LIS should have pre-built interface drivers for all major analyzer brands - Roche, Siemens, Beckman Coulter, Abbott, Sysmex, BD, bioMerieux - so interfaces are configured, not custom-built, at go-live.

Quality control management

CLIA and CAP require documented QC for every analytical run. The LIS QC module receives QC results from the analyzer, plots them on Levey-Jennings charts, applies Westgard multi-rules (1-2s, 1-3s, 2-2s, R-4s, 4-1s, 10-x) automatically, and blocks result release if QC fails. Without automated QC in the LIS, QC review is manual - which means QC failures get missed, and patient results get released on a failed run.

Beyond real-time QC, the LIS should support peer-group comparison (comparing your mean values against a national cohort from CAP or College of American Pathologists proficiency testing programmes) and generate the QC documentation packages required for CLIA/CAP inspection.

Result review, verification, and release

Results flow from the analyzer through the LIS's auto-verification engine. Auto-verification applies configurable rules - if a result is within the reference range, has passed delta check against the previous result, and the QC for that run passed - it can be automatically verified and released to the EHR without manual review. Results outside those parameters are flagged for technologist or pathologist review.

This is where a good LIS pays for itself operationally: a well-configured auto-verification rate of 60-80% means your lab team spends their time on the results that actually need clinical attention, not on routine normals.

Result reporting and delivery

A clinical LIS delivers results through multiple channels: HL7 ORU messages to the ordering EHR, FHIR DiagnosticReport resources for FHIR-capable systems, PDF reports to a patient portal, fax (legacy but still required by many physician practices), and printed hard copies for certain regulatory or patient-preference situations. Critical value notification - automatic alerting to the ordering clinician when a result exceeds a critical threshold (e.g., potassium > 6.5 mEq/L) - is a patient-safety requirement under CLIA and most accreditation standards.

Microbiology and anatomic pathology modules

These two disciplines have workflows distinct enough that a LIS without dedicated modules for them typically forces workarounds.

Microbiology requires culture workflow management: inoculation dates and incubation tracking, organism identification and susceptibility (MIC) entry, antibiogram reporting, infection-control flags, and integration with clinical decision support for antimicrobial stewardship. An anatomic pathology laboratory information system (AP LIS) handles the gross description and block/slide workflow for surgical pathology, cytology, and autopsy: case accession, gross description entry, block and slide labelling, frozen section workflow, transcription of dictated diagnoses, and pathologist sign-out.

If your lab runs microbiology, surgical pathology, or cytology, confirm during the demo that the LIS has dedicated, purpose-built modules for these - not generic specimen-tracking fields repurposed for complex clinical workflows.

Inventory and reagent management

Reagent lot tracking, expiry date management, reorder-point alerts, and lot-to-lot QC comparison. Not the deepest feature in most clinical LIS platforms, but sufficient for managing reagent inventories and generating the lot-usage documentation that CAP inspectors review.

Compliance and accreditation: what your LIS must support

US clinical laboratories operate under a federal regulatory framework that your LIS must accommodate - not work around.

CLIA (Clinical Laboratory Improvement Amendments)

CLIA is the federal law that regulates all US clinical laboratory testing on human specimens. CMS administers CLIA; the FDA classifies test complexity. Your LIS must support CLIA requirements including: documented QC procedures for each analytical system, personnel qualification tracking, proficiency testing (PT) result entry and documentation, audit trails for all result entry and modification, and delta check capability.

A CLIA deficiency for inadequate QC documentation is the most common serious finding in CMS inspections. A LIS that auto-generates QC documentation packages eliminates the manual effort of assembling these records for inspection.

CAP (College of American Pathologists) accreditation

CAP accreditation is voluntary but is accepted by CMS as meeting CLIA requirements, and is required by most Joint Commission-accredited hospitals. CAP's Laboratory Accreditation Program (LAP) checklist items that directly touch LIS functionality include: QC documentation and Westgard rule application, delta check implementation, critical value notification documentation, specimen rejection criteria, and result amendment audit trails.

ISO 15189

ISO 15189 is the international standard for medical laboratory quality and competence. Required for US labs seeking international recognition and increasingly expected by hospital networks with international patient populations. The LIS audit trail, uncertainty of measurement documentation, and proficiency testing tracking are the primary LIS-relevant ISO 15189 requirements.

HIPAA

Laboratory results are protected health information (PHI). Your LIS must support HIPAA's technical safeguards: role-based access control, audit trails for all PHI access, encryption of data at rest and in transit, automatic session timeouts, and the ability to produce access logs for audit investigations. For cloud-based LIS deployments, the vendor must be willing to execute a Business Associate Agreement (BAA).

21 CFR Part 11 (for FDA-regulated labs)

Laboratories performing tests under FDA oversight - certain LDTs (laboratory-developed tests), molecular diagnostics for FDA-cleared analytes, and labs participating in FDA clinical trials - must comply with 21 CFR Part 11, which governs electronic records and electronic signatures. The LIS must produce audit trails, support electronic signatures with user authentication, and ensure records cannot be altered without a documented reason.

What's new in laboratory information systems in 2026

The LIS market is consolidating and evolving faster than it has in the previous decade. Three shifts are worth tracking as you evaluate platforms:

FHIR-based EHR integration replacing custom HL7 interfaces

The traditional LIS-EHR integration model - a custom HL7 v2 interface built point-to-point between the LIS and each EHR - is expensive to build, expensive to maintain, and breaks every time either system upgrades. The shift to FHIR R4 is making this better: FHIR ServiceRequest (order) and DiagnosticReport (result) resources allow standardized, API-based lab data exchange that any FHIR-capable system can consume. Evaluate whether prospective LIS vendors have published FHIR APIs or whether they're still building custom HL7 interfaces. The former is sustainable; the latter is technical debt.

Cloud-based laboratory information systems replacing on-premise servers

A cloud based laboratory information system - the deployment model that now dominates new purchases - eliminates the on-premise server infrastructure that legacy LIS deployments require - the dedicated Windows servers, backup hardware, and IT staff time to maintain them. Cloud LIS platforms offer automatic updates, disaster recovery, and access from any browser-capable device. The primary remaining argument for on-premise LIS is data-residency requirements (VA facilities, certain government labs) or legacy instrument interfacing that requires local network proximity. For most clinical labs, cloud-native is the right default in 2026.

AI-assisted result interpretation and reflex logic

Several LIS vendors are embedding AI models for automated reflex test triggering (e.g., automatically adding a reflex test when an initial screening result exceeds a threshold), flagged result interpretation (flagging a CBC result pattern consistent with a specific haematological disorder for pathologist attention), and predictive TAT management (routing specimens based on predicted turnaround against SLA commitments). This is early-stage in clinical LIS - not all implementations are validated for clinical use - but it's worth asking vendors about their roadmap.

Patient-portal result delivery

Direct patient access to lab results is now a federal requirement under the 21st Century Cures Act information-blocking rule. Your LIS must support a result-delivery pathway to the patient portal - either via a FHIR DiagnosticReport resource to the EHR's portal, or via a direct patient-facing portal integrated with the LIS. Labs that still rely on the physician to relay results to patients are information-blocking under ONC rules.

How to choose a laboratory information system: 8-step framework

Step 1 - Map your test menu and annual volume

Before you look at a single vendor, document what your lab actually does: number of distinct test codes, annual accession volume by department (chemistry, haematology, microbiology, pathology, blood bank), peak daily volume, and any high-complexity or send-out tests that require special handling. This map determines which LIS modules you need and at what throughput level the system must perform.

Step 2 - Inventory your instruments and their interface requirements

List every analyzer in your lab with its manufacturer, model, and current interfacing protocol (ASTM, HL7, proprietary, manual). For each instrument, determine: does the prospective LIS vendor have a pre-built, validated interface driver for this specific model? A pre-built driver means a 1-2 week interface setup during go-live. A custom interface build means 3-6 months and significant additional cost.

Step 3 - Define your EHR/HIS integration touchpoints

Determine which systems send orders to your LIS and which systems need to receive results: the primary hospital EHR or HIS, any satellite clinic EHRs, the billing system (for CPT code extraction), the patient portal, and any external ordering physician systems. For each, confirm the integration protocol available (HL7 ORM/ORU, FHIR, direct API) and whether the LIS vendor has an existing integration with that system.

Step 4 - Confirm compliance fit for your accreditation programme

Map the LIS's built-in compliance features against your specific accreditation requirements (CLIA certificate level, CAP if applicable, ISO 15189 if applicable, 21 CFR Part 11 if applicable, Joint Commission). Ask vendors for the most recent CAP or ISO audit report for their platform - not their marketing materials.

Step 5 - Decide cloud vs on-premise

For most labs in 2026, cloud-native is the right choice: no server hardware, automatic updates, built-in disaster recovery, and access from any device. The exceptions: VA or federally mandated on-premise environments, labs with legacy instruments that require local network TCP/IP connections the cloud model doesn't support, or labs in areas with unreliable internet connectivity. If you're leaning on-premise, model the 5-year total cost of ownership including server refresh, backup infrastructure, and IT staffing - it typically runs 30-50% higher than equivalent SaaS.

Step 6 - Budget for implementation and training

Implementation cost is consistently underestimated. The rule of thumb: implementation and training typically run 25-50% of the first-year license cost. For a mid-size hospital lab, that means a $100,000 annual SaaS licence typically comes with a $30,000-$50,000 implementation project. Implementation includes interface builds (or FHIR configuration), test catalog migration, QC rule configuration, user training (technologists, pathologists, supervisors), and a parallel-run period where both old and new systems run simultaneously before full cut-over. Parallel-run periods of 2-4 weeks are standard; skipping them is a patient-safety risk.

Step 7 - Run a proof-of-concept with your real data

Ask shortlisted vendors for a 30-90 day proof-of-concept (POC) using a representative subset of your actual test menu, instrument interfaces, and EHR integration. The POC should demonstrate auto-verification rates achievable with your test mix, interface stability with your specific analyzer models, and result delivery round-trip time to your EHR. Vendors who won't do a POC on real data are usually protecting you from finding out something you'd want to know before signing.

Step 8 - Negotiate SLAs, support terms, and exit conditions

Healthcare LIS systems have 7-10 year deployment lifespans. Negotiate uptime SLAs (99.9% minimum for cloud; define what "uptime" means - planned maintenance windows matter), critical-bug response times, data-export formats (you must be able to get your data out in a machine-readable format without vendor cooperation if needed), and price escalation caps for multi-year contracts. The exit clause is especially important: labs that have switched LIS vendors without a negotiated data-export right have paid five-figure ransoms to get their historical accession data back.

Laboratory information system pricing and total cost of ownership

Pricing models vary enough between vendors that direct comparison requires normalizing on a per-accession or per-user basis.

Per-accession SaaS pricing is common among cloud-native LIS vendors targeting clinical labs. Typical range: $0.05-$0.25 per accession, with volume discounts above certain thresholds. A lab running 200,000 accessions per year at $0.10/accession = $20,000/year in usage fees, plus a platform fee. This model aligns cost with volume and is predictable for budgeting.

Per-user subscription is common among mid-market platforms. $200-$600 per named user per month for full-featured platforms. A lab with 30 users = $72,000-$216,000/year. Per-user pricing penalizes labs with many occasional users (physicians who occasionally check results); make sure the pricing structure accounts for different user types (full technologist vs read-only physician access).

Perpetual license + AMC (Annual Maintenance Contract) is the legacy model for on-premise platforms. Upfront license fee of $50,000-$500,000+ depending on lab size, followed by an AMC of 18-25% of the license per year. Over 5 years this is typically higher total cost than SaaS at equivalent functionality, once server infrastructure and IT overhead are factored in.

Hidden costs to model:

• Interface build fees ($3,000-$15,000 per instrument interface for non-standard connections)
• Test catalog migration (typically 40-80 hours of professional services)
• Custom report development ($150-$300/hour for non-standard report formats)
• Training (beyond the standard package - additional sessions for new staff, refreshers after upgrades)
• Validation documentation for 21 CFR Part 11 environments (can add 20-40% to implementation cost)

Top 10 laboratory information systems compared

Pricing tiers: $ = under $30K/yr, $ = $30-100K, $$ = $100-300K, $$ = $300K+. All ranges indicative - request vendor quotes against your specific accession volume and module scope.

Specialty workflows: pathology, microbiology, blood bank

A general-purpose clinical LIS handles chemistry, haematology, urinalysis, and immunology well. Three specialty areas warrant specific attention when evaluating:

Anatomic pathology laboratory information system

Surgical pathology and cytology have workflow requirements that are fundamentally different from clinical chemistry. The AP workflow begins with a requisition and a surgical specimen (not a blood tube), moves through grossing and block/slide creation, histological processing, staining, and ends with a pathologist reviewing glass slides or digital whole-slide images and dictating a diagnosis. An anatomic pathology laboratory information system manages all of this: case accession, block and slide labelling (with barcode tracking), frozen section workflow with turnaround time tracking, voice dictation integration, synoptic reporting templates (CAP Cancer Protocols), and pathologist electronic sign-out.

If your lab runs surgical pathology or cytology, this module is non-negotiable. Ask to see it demonstrated on a real pathology case workflow, not a chemistry result entry demo.

Microbiology

Microbiology requires culture workflow management that clinical chemistry LIS modules typically don't provide: inoculation tracking across multiple culture media, incubation time monitoring, organism identification entry (integrated with instruments like the Vitek 2 or MALDI-TOF), antimicrobial susceptibility testing (AST) result entry and interpretation, antibiogram reporting for infection control and antimicrobial stewardship, and infection-control flagging for organisms like MRSA, VRE, and CRE.

Some LIS platforms handle microbiology with a dedicated module; others offer only basic organism-entry fields that require workarounds for complex susceptibility reporting. Ask specifically about AST table management and antibiogram generation.

Blood bank (transfusion medicine)

Blood bank operations involve regulations beyond CLIA and CAP - the FDA's 21 CFR Parts 606 and 610 govern blood product manufacturing and testing. A blood bank LIS must manage: donor eligibility and deferral checking, blood product inventory with unit traceability, compatibility testing (type and screen, crossmatch), transfusion records with patient and unit barcodes, critical value and transfusion reaction documentation, and FDA-required look-back procedures.

Many labs choose a dedicated blood bank information system (BBIS) - standalone platforms like HaemonecticsBloodTrack, Mediware HCLL, or Birlamedisoft BloodBank - that interfaces with the main LIS rather than relying on a LIS's blood bank module. The interface between the BBIS and LIS must be validated per FDA requirements.

Common implementation pitfalls

Underestimating the test catalog build. Most labs have 300-2,000+ test codes in their current system. Migrating these to a new LIS - with all reference ranges, specimen requirements, methodology codes, billing codes, and reflex logic intact - is a 4-8 week project that requires a dedicated lab informatics resource. Rushing it produces a test catalog with errors that surface as patient result problems after go-live.

Skipping the parallel-run period. Running the new LIS alongside the old system for 2-4 weeks before full cut-over lets you catch interface gaps, missing test codes, and QC configuration problems before they affect patient care. Labs that cut over directly (without a parallel run) report go-live problems at 3-4x the rate of those that ran in parallel.

Signing a contract without a data-export clause. Your historical accession data - years of test results, patient records, QC documentation - must be yours to take when you eventually switch systems. Without a negotiated data-export clause, you're dependent on the vendor's goodwill and fee schedule when that day comes. Include: export format (industry-standard, not proprietary), export timeline (30-60 days from request), and whether there's an associated fee.

Choosing a LIS without asking about the upgrade cadence. Legacy LIS platforms have update cycles measured in years. A system that was last updated in 2019 has accumulated five years of regulatory changes (new CLIA requirements, new CAP checklist items, new FHIR mandates) that may require manual workarounds. Ask vendors: how often are updates released, how are updates delivered (automatic cloud push vs. manual on-premise install), and who manages the upgrade project.

Laboratory information system benefits: what changes after go-live

The operational benefits of a modern LIS are measurable, not theoretical. Based on documented go-live outcomes across hospital and reference lab deployments:

• Turnaround time. Automated instrument interfacing and auto-verification eliminate manual result transcription steps - typically reducing TAT for routine chemistry panels by 20-40%.
• Transcription error elimination. Manual result entry produces transcription errors at rates of 0.2-1.0% per entry event. Direct instrument interfacing eliminates this error source entirely.
• QC compliance. Automated Westgard rule application catches QC failures that manual review misses. Labs that move from paper-based QC tracking to LIS-automated QC consistently reduce QC-related CLIA deficiency findings.
• Staff productivity. Auto-verification rates of 60-80% for routine specimens mean technologists spend their time on complex and flagged results, not on verifying normal CBCs. Lab studies have documented 15-25% productivity improvements in labs with well-configured auto-verification.
• Billing accuracy. Automated CPT code assignment from test catalog reduces coding errors that result in claim denials. Most labs see a 3-8% improvement in first-pass billing acceptance rates after LIS go-live.

Frequently asked questions

What is the difference between a LIS and a LIMS?

In clinical laboratory settings, LIS laboratory information system and LIMS (Laboratory Information Management System) refer to the same category of software and are used interchangeably by most vendors and buyers. The historical distinction is that LIMS originated in research and industrial laboratories (emphasising sample management and chain of custody), while LIS originated in clinical diagnostic labs (emphasising result reporting and EHR integration). Modern platforms typically cover both. If a vendor describes their product exclusively as a "LIMS" with no mention of HL7 result delivery or CLIA compliance, confirm their clinical diagnostic lab experience before proceeding.

How much does a laboratory information system cost?

For cloud-based platforms, per-accession pricing typically runs $0.05-$0.25 per accession; per-user subscription pricing runs $200-$600 per user per month. A community hospital lab running 150,000 accessions annually on a cloud LIS typically pays $20,000-$60,000 per year in subscription fees. Implementation and training add 25-50% of the first-year cost. On-premise perpetual-license platforms run $50,000-$500,000+ upfront plus 18-25% annual maintenance. Total 5-year cost of ownership is typically lower for SaaS when infrastructure and IT staffing are included.

How long does LIS implementation take?

A straightforward community hospital lab implementation - cloud deployment, 5-10 instruments, single EHR interface - typically takes 12-16 weeks from contract to live. The timeline is dominated by three activities: test catalog build and validation (4-6 weeks), instrument interface configuration and testing (3-6 weeks per interface, running in parallel), and EHR integration testing (2-4 weeks). Reference labs with 50+ instrument interfaces and multiple EHR connections run 6-12 month implementations. The parallel-run period (2-4 weeks) adds time but should not be skipped.

Is open-source LIMS a good option for a clinical lab?

Open-source platforms like SENAITE (formerly Bika LIMS) have zero license cost but require internal technical capacity to deploy, maintain, and upgrade. For a clinical diagnostic lab operating under CLIA, the ongoing cost of technical staff to maintain the platform, validate CLIA compliance features, and build custom instrument interfaces typically exceeds the license cost savings vs a supported commercial platform. Open-source is most appropriate for research labs, low-volume settings, or organisations with strong internal lab informatics teams. For most clinical labs, the support model of a commercial vendor is worth the licensing cost.

Can a LIS connect to my analyzers?

Yes - connecting to analyzers via ASTM, HL7, or proprietary protocols is a core LIS function. Most modern analyzers (Siemens, Roche, Beckman Coulter, Abbott, Sysmex, bioMerieux, Hologic, BD) have documented interface specifications that LIS vendors use to build pre-certified interface drivers. Before signing a LIS contract, request the vendor's interface driver library and confirm pre-built drivers exist for your specific analyzer models. Older or less common analyzers may require custom interface development - budget $3,000-$15,000 and 4-8 weeks per non-standard interface.

Does a LIS replace the EHR?

No. The LIS and EHR serve different clinical functions and should be integrated, not substituted. The EHR manages the patient's longitudinal clinical record - encounter documentation, diagnoses, medications, orders, and the care plan. The LIS manages the diagnostic laboratory's operational and analytical workflows. The integration between them (HL7 or FHIR) means a physician in the EHR can place a lab order that flows to the LIS, and the result flows back to the EHR and patient portal without manual steps. They are complementary, not competitive, systems. Laboratory information system workflow integration with the EHR - automated order receipt and result delivery - is what eliminates the manual steps that slow TAT and introduce transcription errors.

What is laboratory information system training like?

Modern LIS vendors deliver role-based training - separate tracks for laboratory technologists, supervisors and QC leads, pathologists, and IT/informatics staff. Cloud platforms increasingly deliver training via on-demand video modules supplemented by live virtual sessions for complex workflows. On-site training for a community hospital lab typically runs 3-5 days for initial go-live. Ongoing competency training for new staff is typically the lab's responsibility, supported by vendor-supplied training materials. Budget for ongoing training time - the laboratory is a regulated environment where competency documentation is a CLIA requirement, not optional.

Next steps

A laboratory information system is one of the highest-leverage technology investments a clinical lab makes. The right platform eliminates transcription errors, automates QC compliance, integrates seamlessly with your EHR, and gives lab leadership the turnaround time and volume analytics to manage operations by data rather than intuition.

If your lab operates within a hospital or multi-specialty group evaluating an integrated platform - where the LIS connects natively with the HIMS, pharmacy, blood bank, and PACS without custom interface builds - Birlamedisoft's LIMS (Maxim-LIS / PathoGold) is worth including in your evaluation. It is purpose-built for clinical diagnostic labs and natively integrated with the Quanta HIMS platform.

Request a LIMS demo

Related reading:

• The Complete Guide to Healthcare Data Management (2026) - how your LIMS fits into the broader hospital data architecture
• Blood Bank Management Software: 2026 Guide - the blood bank LIS category in depth

Sources: CMS CLIA | CAP Laboratory Accreditation | ISO 15189 | FDA 21 CFR Part 11 | HL7 FHIR R4